-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

112. Thalassemia and Globin Gene Regulation: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, Biological, sickle cell disease, bone marrow, Diseases, thalassemia, Therapies, red blood cells, Biological Processes, Hemoglobinopathies, gene therapy, Technology and Procedures, Cell Lineage, erythropoiesis, Study Population, Clinically relevant, genomics, transplantation
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Ali T. Taher, MD, PhD, FRCP1, Vip Viprakasit2*, Olivier Hermine3,4, John B. Porter, MA, M.D., FRCP, FRCPath5*, Antonio Piga, MD6, Kevin H.M. Kuo, MD, MSc, FRCPC7, Thomas D. Coates, MD8,9, Ersi Voskaridou10*, Abderrahim Khelif11*, Antonis Kattamis12, Jeevan K. Shetty13*, George Zhang14*, Yu (Olivia) Tian14*, Dimana Miteva13*, Tatiana Zinger13*, Derek Tang14*, Jay T. Backstrom15* and Maria Domenica Cappellini16

1Department of Internal Medicine, American University of Beirut - Medical Center Raid El Solh, Beirut, Lebanon
2Siriraj Hospital, Mahidol University, Bangkok, Thailand
3Imagine Institute, INSERM U1163, University of Paris, Paris, France
4Department of Hematology, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
5University College London, University College London Hospitals, London, United Kingdom
6Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
7Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Division of Hematology, Department of Medicine, University of Toronto, Toronto, ON, Canada
8Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA
9USC Keck School of Medicine, Los Angeles, CA
10Thalassemia and Sickle Cell Center of Laiko General Hospital, Athens, Greece
11Farhat Hached Teaching Hospital, Sousse University, Tunisia
12First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece
13Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
14Bristol Myers Squibb, Princeton, NJ
15Acceleron Pharma, Cambridge, MA
16Fondazione IRCCS Ca’ Granda Policlinico Hospital, University of Milan, Milan, Italy

Matthew P Parker, BS1*, Halyna Fedosyuk, MS1*, Lesya V Novikova, PhD1*, Chad Slawson, PhD1* and Kenneth R Peterson, PhD2

1Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS
2Department of Biochemistry and Molecular Biology, Univ. of Kansas Medical Center, Kansas City, KS

Olivier Hermine, MD, PhD1,2*, Maria Domenica Cappellini3, Ali T. Taher, MD, PhD, FRCP4,5, Thomas D. Coates, MD6,7, Vip Viprakasit8*, Ersi Voskaridou9*, Ashutosh Lal, MD10, Hong Keng Liew11*, Silverio Perrotta12*, Abderrahim Khelif13*, Antonis Kattamis14, Jeevan K. Shetty15*, George Zhang16*, Yu (Olivia) Tian16*, Dimana Miteva15*, Tatiana Zinger15*, Derek Tang16*, Jay T. Backstrom17* and John B. Porter, MA, M.D., FRCP, FRCPath18*

1Imagine Institute, INSERM U1163, University of Paris, Paris, France
2Department of Hematology, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
3Fondazione IRCCS Ca’ Granda Policlinico Hospital, University of Milan, Milan, Italy
4Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
5Department of Internal Medicine, American University of Beirut - Medical Center Raid El Solh, Beirut, Lebanon
6Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA
7USC Keck School of Medicine, Los Angeles, CA
8Siriraj Hospital, Mahidol University, Bangkok, Thailand
9Thalassemia and Sickle Cell Disease Center of Laiko General Hospital, Athens, Greece
10University of California San Francisco Benioff Children’s Hospital, Oakland, CA
11Hospital Sultanah Bahiyah, Alor Setar, Malaysia
12Università degli studi della Campania "Luigi Vanvitelli", Napoli, Italy
13Farhat Hached Teaching Hospital, Sousse University, Tunisia
14First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece
15Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
16Bristol Myers Squibb, Princeton, NJ
17Acceleron Pharma, Cambridge, MA
18University College London, University College London Hospitals, London, United Kingdom

Tippi C. MacKenzie, MD1, Michela Frascoli2*, Renan Sper3*, Billie Rachael Lianoglou, MS4*, Juan Gonzalez Velez3*, Christopher C. Dvorak, MD5, Sandhya Kharbanda, MD6 and Elliott Vichinsky, MD7

1Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, UCSF, San Francisco, CA
2University of Massachusetts, Amherst, MA
3UCSF, SF, CA
4Department of Surgery, UCSF, San Francisco, CA
5Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California, San Francisco, San Francisco, CA
6Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, Benioff Children's Hospital, San Francisco, CA
7Hematology/Oncology, Children's Hosp. & Rsrch. Ctr. Oakland, Oakland, CA

Mark C. Walters, MD1, David H.K. Chui, MD, FRCPC2, John J Farrell, PhD2*, Ashutosh Lal, MD1, Franco Locatelli, MD, PhD3, Janet L. Kwiatkowski, MD, MSCE4,5, John B. Porter, MA, M.D., FRCP, FRCPath6*, Martin G. Sauer, MD7, Isabelle Thuret, MD8*, Suradej Hongeng, MD9, Andreas E. Kulozik, MD, PhD10*, Adrian J. Thrasher, MBBS, PhD, FMedSci11*, Evangelia Yannaki, MD12*, Julia Yang13*, Dustin Whitney, PhD13*, Alexandria Petrusich13*, Richard A. Colvin, MD, PhD13* and Alexis A. Thompson, MD14,15

1UCSF Benioff Children's Hospital Oakland, Oakland, CA
2Boston University School of Medicine, Boston, MA
3The Department of Pediatrics, Sapienza, University of Rome, and the Department of Pediatric Hematology–Oncology, IRCCS Bambino Gesù Children’s Hospital, Rome, Italy
4University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
5The Children's Hospital of Philadelphia, Philadelphia, PA
6Haematology Department, University College London Hospitals, London, United Kingdom
7Medizinische Hochschule Hannover, Hannover, Germany
8Pediatric Hematology, Hôpital de la Timone, Marseille, France
9Mahidol University, Ramathibodi Hospital, Bangkok, Thailand
10University of Heidelberg, Heidelberg, Germany
11UCL Great Ormond Street Institute of Child Health, London, United Kingdom
12G. Papanikolaou Hospital, Thessaloniki, Greece
13bluebird bio, Inc., Cambridge, MA
14Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
15Northwestern University Feinberg School of Medicine, Chicago, IL

Claire Berger, MD1*, Philippe Joly, PhD2*, Serge Pissard, PhD3*, Sandrine Baron-Joly, MD4*, Yoann Huguenin, MD5*, Aurélie Cantais, MD6*, Sophie Brun, MD7*, Cecile GED, MD8*, Catherine Badens, PhD, PharmD9*, Muriel Giansily-Blaizot, MD10*, Aguilar-Martinez Patricia, MD, PhD11 and Isabelle Thuret, MD12*

1Service d’hémato-oncologie pédiatrique, CHU Saint-Etienne, Saint-Etienne, France
2Centre de Biologie,"Biochimie des pathologies érythrocytaires",, Groupement Hospitalier Lyon Est, BRON, France
3Laboratoire de Biochimie Génétique, Hôpital Universitaire Henri Mondor, Créteil, France
4Department of Pediatrics, Nîmes University Hospital,, Nîmes, France
5CHU de Bordeaux, Bordeaux Cedex, FRA
6Neonatal Pediatric Care unit, University Hospital,, Saint-Etienne, France
7Department of Hematological biology, Nîmes University Hospital, Nîmes, France
8INSERM, Bordeaux, FRA
9INSERM, MMG, Aix Marseille Univ, Marseille, France
10Department of Hematological biology, CHU de Montpellier, Montpellier, France
11CHU de Montpellier, Montpellier, France
12Pediatric Onco-Hematology, Thalassemia Reference Center, Timone Enfant Hospital, APHM, Marseille, France

Donald Lavelle, PhD1, Vinzon Ibanez, B.S.1*, Kestis Vaitkus1*, Yogenthiran Saunthararajah, MD2 and Robert E. Molokie, MD3,4

1Department of Medicine, University of Illinois at Chicago, Jesse Brown VA Medical Center, Chicago, IL
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Jesse Brown VA Medical Center, Chicago, IL
4Department of Medicine, Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL

Antonis Kattamis1, Ersi Voskaridou2*, Sophia Delicou3*, Evangelos Klironomos, MD4*, Ioannis Lafiatis5*, Fotini Petropoulou, MD6*, Michael D. Diamantidis, MD, PhD, MSc7, Stylianos Lafioniatis, MD8*, Loukia Evliati9*, Eleni Kapsali, MD, PhD10, Kiki Karvounis-Marolachakis, BS11*, Despoina Timotheatou12* and Alexandra Kourakli, MD, PhD13

1First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece
2Thalassemia and Sickle Cell Disease Center of Laiko General Hospital, Athens, Greece
3Thalassemia and Sickle Cell Unit, Hippocrateion General Hospital, Athens, Greece, Athens, Greece
4Thalassemia and Sickle Cell Unit, "Venizelion" General Hospital, Herakleion, Greece, Herakleion, Greece
5Thalassemia and Sickle Cell Unit, "Vostanio" General Hospital of Mytilini, Mytilini, Greece, Mytilini, Greece
6General Hospital of Athens ‘Georgios Gennimatas’,, Thalassemia Unit,, Athens, Greece
7General Hospital of Larissa, Larissa, Greece
8General Hospital of Volos,, Thalassemia Unit,, Volos, Greece
9Thalassemia and Sickle Cell Unit, General Hospital of Athens "Evaggelismos", Athens, Greece, Athens, Greece
10Department of Hematology, University Hospital of Ioannina, Ioannina, Greece
11Medical Department, Genesis pharma SA, Chalandri, Greece
12GENESIS PHARMA, Athens, ITA
13Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece

*signifies non-member of ASH